Successful Umbilical Cord Blood Transplantation With Reduced-intensity Conditioning for Acute Myeloid Leukemia in a Child With Shwachman-Diamond Syndrome

J Pediatr Hematol Oncol. 2021 Apr 1;43(3):e414-e418. doi: 10.1097/MPH.0000000000001773.

Abstract

Outcomes of patients with Shwachman-Diamond syndrome (SDS) who developed myeloid malignancies are poor because of refractory disease and high hematopoietic stem cell transplantation-related mortality. We herein report a case of a 7-year-old girl with SDS who developed acute myeloid leukemia with monosomy 7. She was successfully treated with chemotherapy followed by unrelated cord blood transplantation with reduced-intensity conditioning consisting of fludarabine, melphalan, and high-dose cytarabine without significant toxicity. Reduced-intensity conditioning presented in this report might be a preferable option for SDS patients with acute myeloid leukemia, although further evaluation in a larger number of similar cases is necessary.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents, Alkylating / therapeutic use
  • Child
  • Cytarabine / therapeutic use
  • Female
  • Fetal Blood / transplantation*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Leukemia, Myeloid, Acute / complications*
  • Leukemia, Myeloid, Acute / therapy*
  • Melphalan / therapeutic use
  • Myeloablative Agonists / therapeutic use
  • Shwachman-Diamond Syndrome / complications*
  • Transplantation Conditioning* / methods
  • Vidarabine / analogs & derivatives
  • Vidarabine / therapeutic use

Substances

  • Antineoplastic Agents, Alkylating
  • Immunosuppressive Agents
  • Myeloablative Agonists
  • Cytarabine
  • Vidarabine
  • fludarabine
  • Melphalan